Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI South East AsiaCPhI South East Asia
Not Confirmed
Not Confirmed
16-18 July, 2025
Not Confirmed
Not Confirmed
04-07 July, 2025
Not Confirmed
Not Confirmed
07-11 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Industry Trade Show
Not Confirmed
04-07 July, 2025
Industry Trade Show
Not Confirmed
07-11 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025
19 Dec 2024
// ACCESSWIRE
https://www.accesswire.com/957184/lexarias-registered-glp-1-study-4-begins-dosing
17 Dec 2024
// ACCESSWIRE
https://www.accesswire.com/956013/esteemed-harvard-medical-school-professor-dr-michael-gibson-appointed-chief-medical-advisor-at-lexaria-bioscience
09 Dec 2024
// ACCESSWIRE
https://www.accesswire.com/951505/liraglutide-processed-with-dehydratech-to-be-studied-in-human-glp-1-study-5
26 Nov 2024
// ACCESSWIRE
https://www.accesswire.com/947132/revolutionizing-healthcare-lexaria-highlights-expanding-therapeutic-benefits-of-glp-1-drugs
25 Nov 2024
// ACCESSWIRE
https://www.accesswire.com/946575/lexarias-glp-1-human-pilot-study-3-completes-dosing-as-scheduled
20 Nov 2024
// ACCESSWIRE
https://www.accesswire.com/944817/all-study-groups-using-dehydratech-processing-outperform-rybelsus-in-body-weight-control-in-lexarias-12-week-glp-1-diabetes-animal-study
ABOUT THIS PAGE